These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15715976)

  • 1. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
    Galvani AP; Novembre J
    Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The geographic spread of the CCR5 Delta32 HIV-resistance allele.
    Novembre J; Galvani AP; Slatkin M
    PLoS Biol; 2005 Nov; 3(11):e339. PubMed ID: 16216086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.
    Lucotte G; Dieterlen F
    Infect Genet Evol; 2003 Nov; 3(4):293-5. PubMed ID: 14636691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for selection at CCR5-Delta32.
    Sabeti PC; Walsh E; Schaffner SF; Varilly P; Fry B; Hutcheson HB; Cullen M; Mikkelsen TS; Roy J; Patterson N; Cooper R; Reich D; Altshuler D; O'Brien S; Lander ES
    PLoS Biol; 2005 Nov; 3(11):e378. PubMed ID: 16248677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
    Faure E; Royer-Carenzi M
    Infect Genet Evol; 2008 Dec; 8(6):864-74. PubMed ID: 18790087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
    Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
    AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.
    Klitz W; Brautbar C; Schito AM; Barcellos LF; Oksenberg JR
    Hum Immunol; 2001 May; 62(5):530-8. PubMed ID: 11334678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?
    Faure E
    Virol J; 2008 Oct; 5():119. PubMed ID: 18925940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.
    Hummel S; Schmidt D; Kremeyer B; Herrmann B; Oppermann M
    Genes Immun; 2005 Jun; 6(4):371-4. PubMed ID: 15815693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5-Δ32 gene variant frequency in the Turkish Cypriot population.
    Fahrioglu U; Ergoren MC; Mocan G
    Braz J Microbiol; 2020 Dec; 51(4):1711-1717. PubMed ID: 32734471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
    Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
    J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
    Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
    Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and the CCR5-Delta32 resistance allele.
    de Silva E; Stumpf MP
    FEMS Microbiol Lett; 2004 Dec; 241(1):1-12. PubMed ID: 15556703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.